WMSA
WVE icon

Weiss Multi-Strategy Advisers’s Wave Life Sciences WVE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45,000
Closed -$382K – 814
2020
Q3 		$382K Buy
+45,000
New +$493K 0.01% 501

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weiss Multi-Strategy Advisers's WVE Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Wave Life Sciences (WVE) in Q4 2020, closing a stake of 45,000 shares — an estimated $382K sold.

Weiss Multi-Strategy Advisers first reported a position in WVE in Q3 2020 and held it in 1 quarter. The position peaked at $382K in Q3 2020. 108 funds tracked by Wall St. Rank hold WVE as of Q4 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Wave Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 45,000 Wave Life Sciences shares in Q4 2020, an estimated $382K.
  • Weiss Multi-Strategy Advisers first reported a position in Wave Life Sciences in Q3 2020 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Wave Life Sciences position peaked at $382K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.